AU2003247810A8 - Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders - Google Patents

Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders

Info

Publication number
AU2003247810A8
AU2003247810A8 AU2003247810A AU2003247810A AU2003247810A8 AU 2003247810 A8 AU2003247810 A8 AU 2003247810A8 AU 2003247810 A AU2003247810 A AU 2003247810A AU 2003247810 A AU2003247810 A AU 2003247810A AU 2003247810 A8 AU2003247810 A8 AU 2003247810A8
Authority
AU
Australia
Prior art keywords
dyslipidemias
related disorders
vascular diseases
therapeutic target
novel therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003247810A
Other versions
AU2003247810A1 (en
Inventor
Mark E Samuels
Chenyan Wu
Michael R Hayden
Alison J Brownlie
Sherrie Rae Tafuri
Ryan R Brinkman
Daniel Chagnovich
Aurobindo Chatterjee
Gary C Donaldson
Marie-Pierre Dube
Yigal P Goldberg
Leonard F Jerva
Ronald G Lafrenier
Erwin Ludwig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenon Pharmaceuticals Inc
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Xenon Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC, Xenon Genetics Inc filed Critical Warner Lambert Co LLC
Publication of AU2003247810A1 publication Critical patent/AU2003247810A1/en
Publication of AU2003247810A8 publication Critical patent/AU2003247810A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
AU2003247810A 2002-06-27 2003-06-27 Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders Abandoned AU2003247810A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39187802P 2002-06-27 2002-06-27
US60/391,878 2002-06-27
PCT/US2003/020410 WO2004003159A2 (en) 2002-06-27 2003-06-27 Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders

Publications (2)

Publication Number Publication Date
AU2003247810A1 AU2003247810A1 (en) 2004-01-19
AU2003247810A8 true AU2003247810A8 (en) 2004-01-19

Family

ID=30000767

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003247810A Abandoned AU2003247810A1 (en) 2002-06-27 2003-06-27 Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders

Country Status (4)

Country Link
EP (1) EP1551856A2 (en)
JP (1) JP2006504407A (en)
AU (1) AU2003247810A1 (en)
WO (1) WO2004003159A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100086526A1 (en) 2007-01-16 2010-04-08 Abraham Hochberg Nucleic acid constructs and methods for specific silencing of h19

Also Published As

Publication number Publication date
WO2004003159A3 (en) 2004-10-21
EP1551856A2 (en) 2005-07-13
AU2003247810A1 (en) 2004-01-19
JP2006504407A (en) 2006-02-09
WO2004003159A2 (en) 2004-01-08

Similar Documents

Publication Publication Date Title
HK1079993A1 (en) Drugs for treating vascular diseases
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
IL169338A0 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
EP1480658A4 (en) Methods of treating vascular disease
AU2003238011A8 (en) Treating vitamin d responsive diseases
HK1081173A1 (en) Phenethanolamine derivative for the treatment of respiratory diseases
PT1522314E (en) Remedies for diseases caused by vascular contraction or dilation
AU2003286567A8 (en) Methods for the treatment of skin disorders
EP1545558A4 (en) 1, 3, 5-triazines for treatment of viral diseases
AU2003278775A8 (en) Porifera-based therapeutic compositions for treating and preventing skin diseases
HK1078784A1 (en) Therapeutic treatment
EP1636160A4 (en) Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
GB0223367D0 (en) Therapeutic treatment
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
GB0210464D0 (en) Therapeutic treatment
AU2003247810A8 (en) Novel therapeutic target for treating vascular diseases, dyslipidemias and related disorders
GB0201025D0 (en) The treatment of degenerative diseases
AU2003274649A8 (en) Diagnostic markers for therapeutic treatment
ZA200407358B (en) Microorganism for genetic therapeutic treatment ofproliferative diseases.
GB0223077D0 (en) Treatment of vascular diseases
AU2002365654A8 (en) Treatment of diseases via the skin
GB0228704D0 (en) Novel therapeutic target
GB0207139D0 (en) Novel therapeutic treatment
GB0207138D0 (en) Novel therapeutic treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 9, PAGE(S) 2547 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME XENON GENETICS, INC., APPLICATION NO. 2003247810, UNDER INID (71) CORRECT THE NAME TO READ XENON GENETICS, INC.; WARNER-LAMBERT COMPANY, LLC